Search research articles
Contact Us
Filters
Showing results (71-80 of 110) with videos related to
Page
of 11
Sort By:
BJU International
|
February 9, 2008
Stage migration and pilot studies of reduced chemotherapy supported by positron-emission tomography findings suggest new combined strategies for stage 2 nonseminoma germ cell tumour
Yasser Haba, Michael V Williams, David E Neal, et al.
The Prostate
|
March 19, 2025
A Phase II, Single Arm, Multicentre Trial of Triamcinolone With a GnRH Analog for Castrate-Resistant Prostate Cancer (TRICREST)
Kenrick Ng, Garima Priyadarshini, Shah-Jalal Sarker, et al.
Clinical Genitourinary Cancer
|
December 3, 2025
GAMMA: Results from a Phase II Study for Relapsed Germ Cell Tumors using an Oxaliplatin-Based Treatment Regimen
Kenrick Ng, Garima Priyadarshini, Aaron Prendergast, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 11, 2005
Phase II trial of vinorelbine and oxaliplatin as first-line therapy in malignant pleural mesothelioma
Dean A Fennell, Jeremy P C Steele, Jonathan Shamash, et al.
Frontiers in Oncology
|
November 13, 2023
Seminoma and dysgerminoma: evidence for alignment of clinical trials and de-escalation of systemic chemotherapy
Georgina E Wood, Christopher P Bunting, Mesel Veli, et al.
American Journal of Cancer Research
|
June 21, 2019
The potential of brentuximab vedotin, alone or in combination with current clinical therapies, in the treatment of testicular germ cell tumors
Marc Yeste-Velasco, Tianyu Guo, Xueying Mao, et al.
Acta Oncologica (Stockholm, Sweden)
|
September 5, 2012
Carboplatin AUC 10 for IGCCCG good prognosis metastatic seminoma
Laura Tookman, Sukaina Rashid, Athena Matakidou, et al.
Eclinicalmedicine
|
March 28, 2024
Consensus and controversy in the management of paediatric and adult patients with ovarian immature teratoma: the Malignant Germ Cell International Consortium perspective
Farzana Pashankar, Matthew J Murray, Joanna Gell, et al.
British Journal of Cancer
|
September 29, 2020
The impact of a supranetwork multidisciplinary team (SMDT) on decision-making in testicular cancers: a 10-year overview of the Anglian Germ Cell Cancer Collaborative Group (AGCCCG)
Jonathan Shamash, Wendy Ansell, Constantine Alifrangis, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
February 22, 2022
Surgical management and outcomes for stage 1 malignant ovarian germ cell tumours: A UK multicentre retrospective cohort study
Radha Graham, Nicola D MacDonald, Michelle Lockley, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 110) with videos related to
Sort By:
Page
of 11
BJU International
|
February 9, 2008
Stage migration and pilot studies of reduced chemotherapy supported by positron-emission tomography findings suggest new combined strategies for stage 2 nonseminoma germ cell tumour
Yasser Haba, Michael V Williams, David E Neal, et al.
The Prostate
|
March 19, 2025
A Phase II, Single Arm, Multicentre Trial of Triamcinolone With a GnRH Analog for Castrate-Resistant Prostate Cancer (TRICREST)
Kenrick Ng, Garima Priyadarshini, Shah-Jalal Sarker, et al.
Clinical Genitourinary Cancer
|
December 3, 2025
GAMMA: Results from a Phase II Study for Relapsed Germ Cell Tumors using an Oxaliplatin-Based Treatment Regimen
Kenrick Ng, Garima Priyadarshini, Aaron Prendergast, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 11, 2005
Phase II trial of vinorelbine and oxaliplatin as first-line therapy in malignant pleural mesothelioma
Dean A Fennell, Jeremy P C Steele, Jonathan Shamash, et al.
Frontiers in Oncology
|
November 13, 2023
Seminoma and dysgerminoma: evidence for alignment of clinical trials and de-escalation of systemic chemotherapy
Georgina E Wood, Christopher P Bunting, Mesel Veli, et al.
American Journal of Cancer Research
|
June 21, 2019
The potential of brentuximab vedotin, alone or in combination with current clinical therapies, in the treatment of testicular germ cell tumors
Marc Yeste-Velasco, Tianyu Guo, Xueying Mao, et al.
Acta Oncologica (Stockholm, Sweden)
|
September 5, 2012
Carboplatin AUC 10 for IGCCCG good prognosis metastatic seminoma
Laura Tookman, Sukaina Rashid, Athena Matakidou, et al.
Eclinicalmedicine
|
March 28, 2024
Consensus and controversy in the management of paediatric and adult patients with ovarian immature teratoma: the Malignant Germ Cell International Consortium perspective
Farzana Pashankar, Matthew J Murray, Joanna Gell, et al.
British Journal of Cancer
|
September 29, 2020
The impact of a supranetwork multidisciplinary team (SMDT) on decision-making in testicular cancers: a 10-year overview of the Anglian Germ Cell Cancer Collaborative Group (AGCCCG)
Jonathan Shamash, Wendy Ansell, Constantine Alifrangis, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
February 22, 2022
Surgical management and outcomes for stage 1 malignant ovarian germ cell tumours: A UK multicentre retrospective cohort study
Radha Graham, Nicola D MacDonald, Michelle Lockley, et al.
Page
of 11